Skip to main content
A

ADHERIUM LIMITED — Investor Relations & Filings

Ticker · ADR ISIN · AU000000ADR1 ASX Manufacturing
Filings indexed 866 across all filing types
Latest filing 2023-07-27 Regulatory Filings
Country AU Australia
Listing ASX ADR

About ADHERIUM LIMITED

https://www.adherium.com

Adherium Limited is a digital health company specializing in the development and commercialization of connected medical devices and software solutions for chronic respiratory management. The company's primary offering is the Hailie® platform, which consists of advanced sensors that attach to various inhaler medications to monitor usage and technique. These sensors transmit data via Bluetooth to a mobile application and a cloud-based portal, providing patients and healthcare providers with real-time insights into medication adherence and respiratory health trends. By facilitating remote patient monitoring and data-driven clinical decisions, Adherium aims to improve health outcomes for individuals living with asthma and chronic obstructive pulmonary disease (COPD). The platform is utilized by healthcare systems, pharmaceutical companies, and clinical research organizations to enhance patient engagement and optimize treatment efficacy.

Recent filings

Filing Released Lang Actions
Quarterly Activities/Appendix 4C Cash Flow Report 9 pages 402.1KB
Regulatory Filings
2023-07-27 English
Adherium enters rapid US commercialisation phase 5 pages 414.6KB
Regulatory Filings
2023-07-26 English
Notification of buy-back - ADR 5 pages 24.4KB
Regulatory Filings
2023-07-23 English
Resignation of Joint Company Secretary 1 page 95.5K
Regulatory Filings
2023-07-05 English
Application for quotation of securities - ADR 7 pages 29.8KB
Regulatory Filings
2023-06-27 English
Change of Auditor 2 pages 100.3KB
Regulatory Filings
2023-06-26 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.